Cargando…
How does flecainide impact RyR2 channel function?
Flecainide, a cardiac class 1C blocker of the surface membrane sodium channel (Na(V)1.5), has also been reported to reduce cardiac ryanodine receptor (RyR2)-mediated sarcoplasmic reticulum (SR) Ca(2+) release. It has been introduced as a clinical antiarrhythmic agent for catecholaminergic polymorphi...
Autores principales: | Salvage, Samantha C., Huang, Christopher L.-H., Fraser, James A., Dulhunty, Angela F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208819/ https://www.ncbi.nlm.nih.gov/pubmed/35713932 http://dx.doi.org/10.1085/jgp.202213089 |
Ejemplares similares
-
Ion channel gating in cardiac ryanodine receptors from the arrhythmic RyR2-P2328S mouse
por: Salvage, Samantha C., et al.
Publicado: (2019) -
Flecainide exerts paradoxical effects on sodium currents and atrial arrhythmia in murine RyR2-P2328S hearts
por: Salvage, S C, et al.
Publicado: (2015) -
Molecular Changes in the Cardiac RyR2 With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
por: Dulhunty, Angela F.
Publicado: (2022) -
Flecainide Paradoxically Activates Cardiac Ryanodine Receptor Channels under Low Activity Conditions: A Potential Pro-Arrhythmic Action
por: Salvage, Samantha C., et al.
Publicado: (2021) -
Simvastatin activates single skeletal RyR1 channels but exerts more complex regulation of the cardiac RyR2 isoform
por: Venturi, Elisa, et al.
Publicado: (2018)